Dr. Mike Lee

Mike Lee has over 25 years experience in the pharmaceutical industry. He was formerly Director at Bristol-Myers Squibb and contributed to the Food & Drug Administration approval of Buspar®, and Serzone®, and the accelerated development and approval of TAXOL®. Dr. Lee is the founder of the Annual Symposium on Clinical and Pharmaceutical Solutions and Analysis (CPSA), held in the US, China, Brazil and Europe, highlighting industry-related applications that focus on real-world experiences with the latest analytical technology and industry initiatives. He received his B.S. degree in Chemistry at the University of Maryland and his M.S. and Ph.D. in Analytical Chemistry from the University of Florida. He currently serves on the Leadership Board for the Department of Chemistry at the University of Florida.

“Focus on the one and the rest will follow”